TGTX logo

TG Therapeutics (TGTX) Revenue

Annual Revenue

$233.66 M
+$230.88 M+8290.02%

December 31, 2023

Summary

Performance

1-Year Change

+8290.02%

3-Year Change

+153625%

5-Year Change

+153625%

15-Year Change

+153625%

TGTX Revenue Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

66.74%
TGTX annual revenue is higher than 66.74% of companies in Healthcare sector

Analysts Estimate

$321.55 M
TGTX annual revenue is currently -27.33% lower than the consensus analysts' forecast

High & Low

All-time High

$233.66 M
TGTX annual revenue is currently at an all-time high

3-Year Low

$2.79 M
TGTX annual revenue is currently +8290.02% above its 3-year low

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2023
TGTX previous annual earnings announcement was published on Dec 31, 2023

Next Annual Earnings Report Date

Feb 28, 2025
TGTX next annual earnings announcement is scheduled for Feb 28, 2025

OtherTGTXprofitabilitymetrics:

Annual EPS

$0.09
TGTX annual earnings per share is $0.09

Annual Net Income

$12.67 M
TGTX annual net profit is $12.67 million

Annual Operating Profit

$20.63 M
TGTX annual operating income is $20.63 million

Annual Gross Profit

$219.53 M
TGTX annual gross profit is $219.53 million

Quarterly Revenue

$83.88 M
+$10.41 M+14.17%

September 30, 2024

Summary

Performance

3-Month Change

+14.17%

1-Year Change

+32.15%

3-Year Change

+421.83%

5-Year Change

+421.83%

TGTX Quarterly Revenue Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

66.63%
TGTX quarterly revenue is higher than 66.63% of companies in Healthcare sector

Analysts Estimate

$100.67 M
TGTX quarterly revenue is currently -16.68% lower than the consensus analysts' forecast

High & Low

All-time High

$165.81 M
TGTX quarterly revenue is currently -49.41% below its historical high of $165.81 million

3-Year Low

$80.00 K
TGTX quarterly revenue is currently >+9900.00% above its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2024
TGTX previous earnings announcement was published on Sep 30, 2024

Next Quarterly Earnings Report Date

Feb 28, 2025
TGTX next earnings announcement is scheduled for Feb 28, 2025

Related metrics

Quarterly Gross Profit

$74.54 M
TGTX quarterly gross profit is $74.54 million

Quarterly Operating Profit

$12.43 M
TGTX quarterly operating income is $12.43 million

Quarterly Net Income

$3.88 M
TGTX quarterly net profit is $3.88 million

Quarterly EPS

$0.02
TGTX quarterly earnings per share is $0.02

TTM Revenue

$264.79 M
-$81.94 M-23.63%

September 30, 2024

Summary

Performance

3-Month Change

-23.63%

1-Year Change

-8.48%

3-Year Change

+1000.95%

5-Year Change

+1000.95%

TGTX TTM Revenue Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

65.03%
TGTX TTM revenue is higher than 65.03% of companies in Healthcare sector

Analysts Estimate

$321.49 M
TGTX TTM revenue is currently -17.64% lower than the consensus analysts' forecast

High & Low

All-time High

$346.73 M
TGTX TTM revenue is currently -23.63% below its historical high of $346.73 million

3-Year Low

$2.78 M
TGTX TTM revenue is currently +9411.14% above its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2024
TGTX previous earnings announcement was published on Sep 30, 2024

Next Quarterly Earnings Report Date

Feb 28, 2025
TGTX next earnings announcement is scheduled for Feb 28, 2025

OtherTGTXprofitabilitymetrics:

TTM Gross Profit

$233.85 M
TGTX TTM gross profit is $233.85 million

TTM Operating Profit

-$505.00 K
TGTX TTM operating income is -$505.00 thousand

TTM Net Income

-$14.36 M
TGTX TTM net profit is -$14.36 million

TTM EPS

-$0.11
TGTX TTM earnings per share is -$0.11

TGTX Revenue Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+8290.0%+32.1%-8.5%
3 y3 years+10000.0%+421.8%+1001.0%
5 y5 years+10000.0%+421.8%+1001.0%

TGTX Revenue Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat high+8290.0%-49.4%>+9999.0%-23.6%+9411.1%
5 y5-yearat high>+9999.0%-49.4%>+9999.0%-23.6%>+9999.0%
alltimeall timeat high>+9999.0%-49.4%-100.0%-23.6%>+9999.0%

TG Therapeutics Revenue History

DateAnnualQuarterlyTTM
Sep 2024
-
$83.88 M(+14.2%)
$264.79 M(-23.6%)
Jun 2024
-
$73.47 M(+15.7%)
$346.73 M(+19.8%)
Mar 2024
-
$63.47 M(+44.4%)
$289.33 M(+23.8%)
Dec 2023
$233.66 M(+8290.0%)
$43.97 M(-73.5%)
$233.66 M(+23.1%)
Sep 2023
-
$165.81 M(+931.6%)
$189.77 M(+689.0%)
Jun 2023
-
$16.07 M(+106.0%)
$24.05 M(+180.6%)
Mar 2023
-
$7.80 M(+9653.8%)
$8.57 M(+207.9%)
Dec 2022
$2.79 M(-58.4%)
$80.00 K(-14.9%)
$2.78 M(-44.6%)
Sep 2022
-
$94.00 K(-84.2%)
$5.03 M(-27.8%)
Jun 2022
-
$594.00 K(-70.5%)
$6.96 M(-12.0%)
Mar 2022
-
$2.02 M(-13.1%)
$7.91 M(+18.3%)
Dec 2021
$6.69 M(+4300.7%)
$2.32 M(+14.3%)
$6.69 M(+51.8%)
Sep 2021
-
$2.03 M(+31.4%)
$4.41 M(+82.5%)
Jun 2021
-
$1.54 M(+94.8%)
$2.41 M(+166.2%)
Mar 2021
-
$793.00 K(+1986.8%)
$907.00 K(+496.7%)
Dec 2020
$152.00 K(0.0%)
$38.00 K(0.0%)
$152.00 K(0.0%)
Sep 2020
-
$38.00 K(0.0%)
$152.00 K(0.0%)
Jun 2020
-
$38.00 K(0.0%)
$152.00 K(0.0%)
Mar 2020
-
$38.00 K(0.0%)
$152.00 K(0.0%)
Dec 2019
$152.00 K(0.0%)
$38.00 K(0.0%)
$152.00 K(0.0%)
Sep 2019
-
$38.00 K(0.0%)
$152.00 K(0.0%)
Jun 2019
-
$38.00 K(0.0%)
$152.00 K(0.0%)
Mar 2019
-
$38.00 K(0.0%)
$152.00 K(0.0%)
Dec 2018
$152.00 K(0.0%)
$38.00 K(0.0%)
$152.00 K(0.0%)
Sep 2018
-
$38.00 K(0.0%)
$152.00 K(0.0%)
Jun 2018
-
$38.00 K(0.0%)
$152.00 K(0.0%)
Mar 2018
-
$38.00 K(0.0%)
$152.00 K(0.0%)
Dec 2017
$152.00 K(0.0%)
$38.00 K(0.0%)
$152.00 K(+0.2%)
Sep 2017
-
$38.00 K(0.0%)
$151.70 K(-0.1%)
Jun 2017
-
$38.00 K(0.0%)
$151.80 K(-0.1%)
Mar 2017
-
$38.00 K(+0.8%)
$151.90 K(-0.1%)
Dec 2016
$152.00 K(-0.3%)
$37.70 K(-1.0%)
$152.00 K(-0.3%)
Sep 2016
-
$38.10 K(0.0%)
$152.40 K(0.0%)
Jun 2016
-
$38.10 K(0.0%)
$152.40 K(0.0%)
Mar 2016
-
$38.10 K(0.0%)
$152.40 K(0.0%)
DateAnnualQuarterlyTTM
Dec 2015
$152.40 K(0.0%)
$38.10 K(0.0%)
$152.40 K(0.0%)
Sep 2015
-
$38.10 K(0.0%)
$152.40 K(0.0%)
Jun 2015
-
$38.10 K(0.0%)
$152.40 K(0.0%)
Mar 2015
-
$38.10 K(0.0%)
$152.40 K(0.0%)
Dec 2014
$152.40 K(0.0%)
$38.10 K(0.0%)
$152.40 K(0.0%)
Sep 2014
-
$38.10 K(0.0%)
$152.40 K(0.0%)
Jun 2014
-
$38.10 K(0.0%)
$152.40 K(0.0%)
Mar 2014
-
$38.10 K(0.0%)
$152.40 K(0.0%)
Dec 2013
$152.40 K(+702.1%)
$38.10 K(0.0%)
$152.40 K(+14.3%)
Sep 2013
-
$38.10 K(0.0%)
$133.30 K(+40.0%)
Jun 2013
-
$38.10 K(0.0%)
$95.20 K(+66.7%)
Mar 2013
-
$38.10 K(+100.5%)
$57.10 K(+200.5%)
Dec 2012
$19.00 K(-99.3%)
$19.00 K(>+9900.0%)
$19.00 K(-99.7%)
Dec 2001
$2.71 M(-49.4%)
-
-
Jun 2001
-
$0.00(-100.0%)
$5.71 M(-20.1%)
Mar 2001
-
$2.71 M(+40.8%)
$7.15 M(+33.3%)
Dec 2000
$5.36 M(+346.6%)
$1.93 M(+79.6%)
$5.36 M(+23.7%)
Sep 2000
-
$1.07 M(-25.2%)
$4.33 M(+21.7%)
Jun 2000
-
$1.43 M(+55.0%)
$3.56 M(+67.5%)
Mar 2000
-
$925.50 K(+2.8%)
$2.13 M(+77.1%)
Dec 1999
$1.20 M(-52.0%)
$900.00 K(+200.0%)
$1.20 M(+300.0%)
Sep 1999
-
$300.00 K(>+9900.0%)
$300.00 K(+200.0%)
Jun 1999
-
$0.00(0.0%)
$100.00 K(-96.2%)
Mar 1999
-
$0.00(-100.0%)
$2.60 M(-3.7%)
Dec 1998
$2.50 M(+2400.0%)
-
-
Sep 1998
-
$100.00 K(-96.0%)
$2.70 M(0.0%)
Jun 1998
-
$2.50 M(+2400.0%)
$2.70 M(+800.0%)
Mar 1998
-
$100.00 K(0.0%)
$300.00 K(0.0%)
Dec 1997
$100.00 K(0.0%)
-
-
Sep 1997
-
$100.00 K(0.0%)
$300.00 K(0.0%)
Jun 1997
-
$100.00 K(0.0%)
$300.00 K(0.0%)
Mar 1997
-
$100.00 K(0.0%)
$300.00 K(0.0%)
Dec 1996
$100.00 K
-
-
Sep 1996
-
$100.00 K(0.0%)
$300.00 K(+50.0%)
Jun 1996
-
$100.00 K(0.0%)
$200.00 K(+100.0%)
Mar 1996
-
$100.00 K
$100.00 K

FAQ

  • What is TG Therapeutics annual revenue?
  • What is the all time high annual revenue for TG Therapeutics?
  • What is TG Therapeutics annual revenue year-on-year change?
  • What is TG Therapeutics quarterly revenue?
  • What is the all time high quarterly revenue for TG Therapeutics?
  • What is TG Therapeutics quarterly revenue year-on-year change?
  • What is TG Therapeutics TTM revenue?
  • What is the all time high TTM revenue for TG Therapeutics?
  • What is TG Therapeutics TTM revenue year-on-year change?

What is TG Therapeutics annual revenue?

The current annual revenue of TGTX is $233.66 M

What is the all time high annual revenue for TG Therapeutics?

TG Therapeutics all-time high annual revenue is $233.66 M

What is TG Therapeutics annual revenue year-on-year change?

Over the past year, TGTX annual revenue has changed by +$230.88 M (+8290.02%)

What is TG Therapeutics quarterly revenue?

The current quarterly revenue of TGTX is $83.88 M

What is the all time high quarterly revenue for TG Therapeutics?

TG Therapeutics all-time high quarterly revenue is $165.81 M

What is TG Therapeutics quarterly revenue year-on-year change?

Over the past year, TGTX quarterly revenue has changed by +$20.41 M (+32.15%)

What is TG Therapeutics TTM revenue?

The current TTM revenue of TGTX is $264.79 M

What is the all time high TTM revenue for TG Therapeutics?

TG Therapeutics all-time high TTM revenue is $346.73 M

What is TG Therapeutics TTM revenue year-on-year change?

Over the past year, TGTX TTM revenue has changed by -$24.54 M (-8.48%)